AÇAlev Çinar

Alev Çinar

*This is an algorithmically generated author record based on publicly available information.

Alev Çinar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Üreterde Cut-off İşareti

    by Alev Çinar, Abdulbaki Erkovan, Ibrahim Kiliccalan, Aslı AYAN

    Obstructive uropathy occurs due to common causes such as kidney stones, vesicoureteral reflux, posterior urethral valve and urothelial tumors. In addition, there are rare causes such as solid tumors, retroperitoneal fibrosis, primary lymphomas (Non-Hodgkin lymphomas etc.). A 20-year old male with lower back pain underwent a bone scan for differential diagnosis of back pain. The bone scan findings were normal, except for the presence of unilateral renal stasis accompanied by a short segment ureteral stasis. Due to the abrupt termination of the ureteral activity, namely the “cutoff sign”, a subsequent SPECT/CT imaging was focused for differential diagnosis of ureteral stasis. Non-diagnostic CT sections revealed a para-aortic soft tissue mass compressing the ureter. This case underlines the added value of SPECT/CT imaging in subtle scintigraphic findings. The abrupt termination of stasis in the ureter may warrant the application of SPECT/CT in cases with no previous history of urinary tract pathology. SPECT / CT may provide additional benefits of clarifying the etiology.

  • Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the postoperative clinical management of patients with colorectal cancer

    by Alev Çinar, Engin Alagöz, Aslı AYAN, Aybüke Uçgun

    Objective: Colorectal cancer (CRC) is a well-known, surgically curable type of cancer if detected early. Survival rate increase depends on the early detection of the recurrent lesions. In this present study, we aimed to emphasize the value of the F-18 FDG PET/CT imaging modality to evaluate the postoperative treatment response of patients with CRC, based on our clinical experience. Methods: Between January 2016 and January 2020, 168 colorectal cancer patients underwent F-18 FDG PET/CT to evaluate residue/recurrence cancer in our institution. Patients enrolled in this study were operated on for primary colon tumors. Before and after systemic therapy, all patients underwent pre and post-treatment F-18 FDG PET/CT to assess treatment response. The images were analyzed retrospectively. Results: Patients were classified according to primary tumor localization. Of 168 patients, the primary tumor localized in the ascending colon (n=55), the descending colon (n=33), the transverse colon (n=14), the rectosigmoid (n=61), and the caecum in the other five patients. Recurrence of primary tumor site was detected in 57 patients; 33 of them were male (57.9%) and 24 female (42.1%). The mean SUVmax of the local recurrent lesion was 8.97 ± 3.42 g/ml. In addition, from the ascending colon group, two patients had new foci of tumoral lesions (1.20%). Conclusion: Resection of the colonic segments with tumor, if possible, is the first step in the treatment of patients with colorectal cancer. After the curative operation, recurrence can be seen in approximately 40% of patients within the first two years. Early detection of recurrence improves the survival rate.

  • Open Access

    The value of FDG PET/CT in the management of malignant melanoma: a retrospective study

    by Alev Çınar, Semra Ince, Ülkü Nur Göker

    Objectives: Positron Emission Tomography with Computed Tomography (PET/CT) is a valuable imaging method for the restaging of malignant diseases as well as the evaluation of treatment outcomes. Malignant melanoma is an aggressive tumor. Surgical resection is the primary treatment. As melanoma lesions are mostly FDG-avid, whole-body 18F-fluorodeoxyglucose (18F-FDG) PET/CT imaging modality can be used to determine the spread of the tumor. In the present study, we intended to share our clinical experience with FDG PET/CT in malignant melanoma patients under different kinds of treatment. Methods: In this retrospective study, the data sets of 122 patients who had surgical resection of known primary tumors, all of which were histopathology-proven malignant melanoma, were analyzed. All patients underwent baseline 18F-FDG PET/CT scan no sooner than 45 days and at least once after surgery. Clinical information, radiological imaging, histopathology, and treatment modalities were noted for all patients, and 18F-FDG PET/CT findings were examined. Results: All patients were histopathology-proven and 47 of them had acral lentiginous, 37 nodular, 23 amelanotic, and 15 atypical malignant melanoma. Local recurrence was detected by 18F-FDG PET/CT in 13 (10.6%; 3 male, 10 female) of the 122 patients, and the mean recurrence time after diagnosis was 3 ± 1.4 years. 10 patients with brain and bone metastases underwent radiotherapy. 19 patients with lung, bone, and hepatic metastases received chemotherapy and 22 patients immunotherapy. Conclusions: Malignant melanoma is a type of skin cancer that may involve any organ. In localized cases, complete surgical resection may be adequate for a cure. If diagnosed with the latter type, the whole body of the patient must be examined.